Vir Biotechnology, Inc. (NASDAQ:VIR) presented initial Phase 1 data from two of its dual-masked T-cell engagers (TCEs): VIR-5818, which targets a variety of HER2-expressing solid tumors, and VIR-5500, ...

US stocks plunged Friday as investors digested a better-than-expected jobs report that soured expectations of future rate ...

LPL also drew from Osaic again, RIA aggregators made some big M&A deals and Merrill rehired an executive who left to go to ...

When the December nonfarm payrolls report hit the tape, there was no question which way stocks would go at Friday's opening ...

U.S. bank JPMorgan Chase on Friday asked its employees who are on hybrid work schedules to return to the office five days a ...

These 173 leaders will help steer the firm as Wall Street readies for a potential flood of dealmaking, from M&A to IPOs.

Here's some key corporate earnings, economic data releases, and other events to watch for in the coming week. Monday, Jan. 13 ...

Morgan Stanley closed $12.79 short of its 52-week high ($136.24), which the company achieved on November 25th.

JPMorgan Chase & Co. will largely end remote work and require most of its employees to return to the office five days per ...

Taiwan Semiconductor Manufacturing Co.’s quarterly sales topped estimates, reinforcing investor hopes that the torrid pace of ...

JP Morgan this week became the latest to announce its withdrawal from Net Zero Banking Alliance, joining Goldman Sachs, ...

Morgan Stanley upgraded Gilead Sciences Inc (NASDAQ:GILD) to "overweight" from "equal weight," raising its price target to ...